Linking atrial fibrillation to cerebral small vessel disease: a cross-sectional study with predictive analytics
By
Jingzhou Shang
Lu Fan
Jing Xu
Xiaofei Sui
May 20, 2026
Clinical Scorecard: Examining the Relationship Between Atrial Fibrillation and Cerebral Small Vessel Disease: A Cross-Sectional Analysis Utilizing Predictive Modeling
At a Glance
Category Detail
Condition Atrial Fibrillation and Cerebral Small Vessel Disease Key Mechanisms Microembolization, cerebral hypoperfusion, systemic inflammation Target Population Older adults aged ≥70 years Care Setting Population-based study with MRI imaging
Key Highlights
AF is associated with higher WMH volumes, particularly in men and those on anticoagulation therapy. AF increases odds of symptomatic stroke (OR: 4.2) and prevalence of silent brain infarcts. Predictive models show high accuracy for WMH burden (81.2%) and stroke risk (84.9%). Guideline-Based Recommendations
Diagnosis
Identify AF via ECG, self-reports, and hospital records. Quantify CSVD markers using standardized MRI protocols. Management
Consider anticoagulation therapy for stroke prevention in AF patients. Monitoring & Follow-up
Regular assessment of WMH burden and stroke risk in patients with AF. Risks
Increased risk of cognitive decline and stroke associated with AF and CSVD. Patient & Prescribing Data
Individuals aged ≥70 years with AF
Anticoagulation therapy may modulate CSVD pathology.
Clinical Best Practices
Implement targeted strategies to mitigate AF-related brain injury. Stratify treatment approaches based on sex and age of AF onset. Related Resources & Content
